Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease

Sui Lung Su, Wei Teing Chen, Po Jen Hsiao, Kuo Cheng Lu, Yuh Feng Lin, Chin Lin, Wen Su, Shih Jen Yeh, Hung Chang, Fu Huang Lin

研究成果: 雜誌貢獻文章

摘要

Single nucleotide polymorphisms (SNPs) in renin-angiotensin system (RAS) genes are associated with RAS imbalance and chronic kidney disease (CKD). We performed a case-control study and meta-analysis to investigate the association between angiotensinogen (AGT) M235T polymorphism and CKD. A total of 634 patients with end-stage renal disease and 739 healthy controls were studied. We also searched PubMed and the Cochrane Library to identify prospective observational studies published before December 2015. We found that the TT and MT genotypes were associated with a higher risk of CKD than the MM genotype (odds ratio [OR]: 3.56; 95% confidence interval [CI]: 1.14-11.16 and OR: 2.93; 95% CI: 0.91-9.46, respectively). Thirty-eight study populations were included in the meta-analysis. The T allele was associated with a higher risk of CKD than the M allele in all populations (OR: 1.19; 95% CI: 1.08-1.32). The OR was 1.33 in Asians (95% CI: 1.06-1.67) and 1.10 in Caucasians (95% CI: 1.02-1.18). Evaluation of gene-gene and geneenvironment interactions using epistasis analysis revealed an interaction between AGT M235T and angiotensin II receptor type 1 A1166C in CKD (OR: 0.767; 95% CI: 0.609-0.965). Genetic testing for CKD in high-risk individuals may be an effective strategy for CKD prevention.

原文英語
頁(從 - 到)107833-107843
頁數11
期刊Oncotarget
8
發行號64
DOIs
出版狀態已發佈 - 一月 1 2017

    指紋

ASJC Scopus subject areas

  • Oncology

引用此

Su, S. L., Chen, W. T., Hsiao, P. J., Lu, K. C., Lin, Y. F., Lin, C., Su, W., Yeh, S. J., Chang, H., & Lin, F. H. (2017). Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease. Oncotarget, 8(64), 107833-107843. https://doi.org/10.18632/oncotarget.22121